Benefits of OSA patient phenotyping

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/27/08/6f/27086f32-b85a-d995-5580-63b960cb00a5/mza_1276740992085879271.jpg/600x600bb.jpg

OnAir, with Clinical Respiratory News

Clinical Respiratory News

17 episodes

9 months ago

Listen to OnAir with Clinical Respiratory News, the podcast about respiratory care and sleep-disordered breathing. In each episode we’ll be airing our thoughts on the latest research, trends and events in COPD and OSA, NIV and HFT, digital health and new technologies. Join our presenters as they interview clinical experts and bring you lively discussions and thought-provoking insights on recent studies and hot topics. Make sure you make time for OnAir! This content is intended for health professionals only.

Medicine

Health & Fitness

RSS

All content for OnAir, with Clinical Respiratory News is the property of Clinical Respiratory News and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

Benefits of OSA patient phenotyping

OnAir, with Clinical Respiratory News

18 minutes 35 seconds

1 year ago

Benefits of OSA patient phenotyping

In this episode of OnAir, sleep clinician Prof. Dr Manuel Sánchez-de-la-Torre and host Daniela Ehrsam-Tosi discuss the potential benefits of patient phenotyping for obstructive sleep apnoea. Prof. Dr Sánchez-de-la-Torre explores why patient phenotyping can be relevant during diagnosis, for making effective treatment decisions, and during the follow-up stage. He highlights the role of patient phenotype in predicting responses and understanding neutral effects, with a particular focus on blood pressure and hypoxic burden. He also emphasises the value of telemedicine in promoting engagement and treatment adherence. Listen to learn why progress in patient phenotyping could affect the way you treat and understand your OSA patients. Guest: Prof. Manuel Sánchez-de-la-Torre - University of Lleida, principal Investigator of the ‘Precision Medicine in Chronic Disease Group’ at the Biomedical Research Institute of Lleida, Spain. Host: Daniela Gautschi is ResMed’s Director Clinical Advocacy Europe, and has a passion for exploring the latest developments in the world of sleep and breathing health. Her key focus is advocating for digital health innovations to help ensure access to good quality care. Reference: Sánchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, et al. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA. 2023;330(13):1255–1265. https://doi.org/10.1001/jama.2023.17465 The podcast OnAir, with Clinical Respiratory News (CRN) is a medical education non-promotional for healthcare professionals organised by ResMed. Learn more at https://webinars.resmed.eu/podcasts-list/. This podcast is intended for healthcare professionals only. Disclaimer: This programme is non promotional and is sponsored by ResMed. The speakers are being compensated and/or receiving an honorarium from ResMed in connection with this programme. The content contained in this programme was jointly developed by the speakers and ResMed, and is not eligible for continuing medical education (CME) credits. Listen to OnAir with Clinical Respiratory News, the podcast that brings you fresh insights and thought-provoking discussions about hot topics in sleep and breathing health. © ResMed